Since all but one patient on lumacaftor/ivacaftor had normalization of GGT and GPR, sensitive markers of early liver fibrosis,9 this may have obscured our ability to detect any subsequent change with elexacaftor/tezacaftor/ivacaftor. Here, ALDH18A1 is linked to Hepatic fibrosis.